Temoporfin

Chemical formula: C₄₄H₃₂N₄O₄  Molecular mass: 680.764 g/mol 

Therapeutic indications

Temoporfin is indicated for:

Head and neck squamous cell carcinoma

Population group: only adults (18 years old or older)

Temoporfin is indicated for the palliative treatment of patients with advanced head and neck squamous cell carcinoma failing prior therapies and unsuitable for radiotherapy, surgery or systemic chemotherapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Temoporfin is contraindicated in the following cases:

Porphyria

Porphyria

Surgical procedure

Surgical procedure

Ocular slit lamp examination

Ocular slit lamp examination

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.